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Myocardial bridge is deﬁned as the intramyocardial course of a segment of a coronary artery. Digoxin
increases the force of myocardial contraction, which augments the compression of the vessel. An 86-
year-old woman was admitted to hospital because of chest tightness on exertion. Coronary angiog-
raphy showed a myocardial bridge in the left anterior descending coronary artery that was absent 6 years
previously. There was >80% reduction in the minimal luminal diameter during systole. Digoxin was
discontinued. Repeat coronary angiography performed approximately 4 months later revealed that
systolic compression of the myocardial bridge had decreased signiﬁcantly, and the reduction was <20%.
Digoxin treatment resulted in vigorous vascular contraction in this octogenarian.
Copyright © 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Myocardial bridges occur in as many as 4e80% of patients on
autopsy1. Functional myocardial bridging is less commonly observed
on angiography1. The extent of coronary obstruction by the
myocardial bridge depends on the degree of cardiac contractility2.
Digoxin increases the force of myocardial contraction, which aug-
ments the degree of coronary obstruction during systole. We report
an octogenarian with vascular contraction mimicking severe
myocardial bridge resulting from digoxin treatment. We believe this
patient to be one of the oldest in which this situation is reported.
2. Case report
An 86-year-old woman experienced chest tightness upon
exertion and was admitted to the hospital. She had a history of
atrial ﬁbrillation, stroke, coronary artery disease, hypertension,
bronchial asthma, and chronic kidney disease; all of which were
managed in one hospital. She had undergone coronary angioplasty
with stenting of the right coronary artery at another hospital 9re that they have no conﬂicts
ent of Cardiology, Hsinchu
uangfu Road, Hsinchu City,
. Wong).
tric Emergency & Critical Care Med
es/by-nc-nd/4.0/).years prior to this admission. Coronary angiography, performed 3
years after the stent placement, showed no signiﬁcant in-stent
restenosis. Moreover, the mid, left anterior descending artery
showed no angiographically visible myocardial bridge (Figure 1).
The patient was not being treated with digoxin at that time.
On the day of admission, the patient's blood pressure was 132/
68 mm Hg, and her pulse was 69 beats/min. The physical exami-
nation was unremarkable except for an irregular heart rhythm. Her
medication included digoxin, warfarin, perindopril, indapamide,
nicorandil, hydroxyzine, folic acid, fenoterol, and pentoxifylline.
The patient underwent cardiac catheterization on the following
day. Coronary angiography showed a severe myocardial bridge in
the mid, left anterior descending coronary artery (Figure 2) with
>80% reduction in the minimal luminal diameter during systole.
Digoxin was discontinued, and the patient's exertional chest
tightness was relieved.
Approximately 4 months later, the patient was readmitted due
to chest tightness and leg edema. Her blood pressure was 114/62
mm Hg, and her pulse was 78 beats/min. Upon repeat coronary
angiography, the mid, left anterior descending coronary artery
showed only a mild myocardial bridge (Figure 3). There was <20%
reduction in the minimal luminal diameter during systole.
3. Discussion
The hemodynamic impact of myocardial bridging depends on
the length, thickness, and location of the bridge, as well asicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC
Figure 1. Coronary angiography shows no signiﬁcant systolic compression of the mid, left anterior descending artery. (A) Systole. (B) Diastole.
Figure 2. Coronary angiography shows (A) marked systolic compression of the mid, left anterior descending artery that (B) completely resolved during diastole.
Figure 3. Coronary angiography shows only (A) mild systolic compression of the mid, left anterior descending artery that (B) completely resolved during diastole.
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arterial pressure, and coronary vasomotion3. Coronary resistance,
coronary perfusion pressure, and left ventricular contractility also
play important roles in coronary compression and modulating
coronary blood ﬂow4,5.
Digoxin increases the force of myocardial contraction, which
augments the compression of the vessel in the myocardium.
Digoxin inhibits the Naþ-Kþ-ATPase pump, thereby promoting
NaþeCa2þ exchange, which results in an inﬂux of intracellular Ca2þ
and increased myocardial contraction strength6.
Nitrates decrease preload and reduce the intrinsic coronary wall
tension, and increase the reﬂex sympathetic stimulation of
contractility1,2. When coronary vascular preload is reduced, the
extravascular compression causes a larger coronary ﬂow reduction.
The patient received 1 mg isosorbide dinitrate injected into a
vascular access port during both the initial and follow-up cardiac
catheterization. Nitroglycerin was not given. In this patient, the
change in the degree of coronary obstruction should not be related
to the nitrates.
Treatment of symptomatic patients with myocardial bridging
consists primarily of pharmacological therapy. b-Blockers remain
the mainstay of treatment by decreasing the heart rate, increasing
diastolic coronary ﬁlling period, and decreasing contractility and
compression of the coronary arteries1,3. Percutaneous coronary
intervention, myotomy, or coronary artery bypass grafting may beconsidered for selected patients refractory to maximal medical
therapy.
In conclusion, digoxin treatment resulted in vigorous vascular
contraction mimicking severe myocardial bridge in this octoge-
narian. While it is not clear whether digoxin would have similar
adverse effects in other patients, digoxin should be discontinued in
patients with symptomatic myocardial bridging as a precaution. A
large study of the impact and mechanisms of digoxin on vascular
functions in patients stratiﬁed by age is needed.References
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